Koyfin Home > Directory > Health Care > Revance Therapeutics > Total Assets

Revance Therapeutics Total Assets Chart (RVNC)

Revance Therapeutics annual/quarterly Total Assets from 2012 to 2020.
  • Revance Therapeutics Total Assets for the quarter ending June 06, 2020 was $576m a 53.87% increase of 310m year over year
  • Revance Therapeutics Total Assets for the last 12 months ending June 06, 2020 was $576m a 53.87% increase of 310m year over year
  • Revance Therapeutics Annual Total Assets for 2019 was $340m a 33.48% increase of 114m from 2018
  • Revance Therapeutics Annual Total Assets for 2018 was $226m a -30.64% decrease of -69m from 2017
  • Revance Therapeutics Annual Total Assets for 2017 was $296m a 30.89% increase of 91m from 2016
Other Balance Sheet Metrics:
  • Revance Therapeutics Other Liabilities for the quarter ending September 09, 2018 was $19m a 68.91% increase of 13m year over year
  • Revance Therapeutics Total Equity for the quarter ending September 09, 2018 was $182m a -47.64% decrease of -87m year over year
View Chart On Koyfin

Quarterly RVNC Total Assets Data

06/2020$576m
03/2020$593m
12/2019$340m
09/2019$266m
06/2019$296m
03/2019$324m
12/2018$226m
09/2018$233m
06/2018$259m
03/2018$285m

Annual RVNC Total Assets Data

2019$340m
2018$226m
2017$296m
2016$204m
2015$276m
2014$192m
2013$23m
2012$13m
2011$40m